Wen‐wai Yim

CL
h-index6
3papers
163citations
Novelty37%
AI Score36

3 Papers

18.1CLJun 3, 2023
ACI-BENCH: a Novel Ambient Clinical Intelligence Dataset for Benchmarking Automatic Visit Note Generation

Wen-wai Yim, Yujuan Fu, Asma Ben Abacha et al. · uw

Recent immense breakthroughs in generative models such as in GPT4 have precipitated re-imagined ubiquitous usage of these models in all applications. One area that can benefit by improvements in artificial intelligence (AI) is healthcare. The note generation task from doctor-patient encounters, and its associated electronic medical record documentation, is one of the most arduous time-consuming tasks for physicians. It is also a natural prime potential beneficiary to advances in generative models. However with such advances, benchmarking is more critical than ever. Whether studying model weaknesses or developing new evaluation metrics, shared open datasets are an imperative part of understanding the current state-of-the-art. Unfortunately as clinic encounter conversations are not routinely recorded and are difficult to ethically share due to patient confidentiality, there are no sufficiently large clinic dialogue-note datasets to benchmark this task. Here we present the Ambient Clinical Intelligence Benchmark (ACI-BENCH) corpus, the largest dataset to date tackling the problem of AI-assisted note generation from visit dialogue. We also present the benchmark performances of several common state-of-the-art approaches.

8.3CLSep 15, 2025
MORQA: Benchmarking Evaluation Metrics for Medical Open-Ended Question Answering

Wen-wai Yim, Asma Ben Abacha, Zixuan Yu et al.

Evaluating natural language generation (NLG) systems in the medical domain presents unique challenges due to the critical demands for accuracy, relevance, and domain-specific expertise. Traditional automatic evaluation metrics, such as BLEU, ROUGE, and BERTScore, often fall short in distinguishing between high-quality outputs, especially given the open-ended nature of medical question answering (QA) tasks where multiple valid responses may exist. In this work, we introduce MORQA (Medical Open-Response QA), a new multilingual benchmark designed to assess the effectiveness of NLG evaluation metrics across three medical visual and text-based QA datasets in English and Chinese. Unlike prior resources, our datasets feature 2-4+ gold-standard answers authored by medical professionals, along with expert human ratings for three English and Chinese subsets. We benchmark both traditional metrics and large language model (LLM)-based evaluators, such as GPT-4 and Gemini, finding that LLM-based approaches significantly outperform traditional metrics in correlating with expert judgments. We further analyze factors driving this improvement, including LLMs' sensitivity to semantic nuances and robustness to variability among reference answers. Our results provide the first comprehensive, multilingual qualitative study of NLG evaluation in the medical domain, highlighting the need for human-aligned evaluation methods. All datasets and annotations will be publicly released to support future research.

7.1LGSep 9, 2025
CancerGUIDE: Cancer Guideline Understanding via Internal Disagreement Estimation

Alyssa Unell, Noel C. F. Codella, Sam Preston et al.

The National Comprehensive Cancer Network (NCCN) provides evidence-based guidelines for cancer treatment. Translating complex patient presentations into guideline-compliant treatment recommendations is time-intensive, requires specialized expertise, and is prone to error. Advances in large language model (LLM) capabilities promise to reduce the time required to generate treatment recommendations and improve accuracy. We present an LLM agent-based approach to automatically generate guideline-concordant treatment trajectories for patients with non-small cell lung cancer (NSCLC). Our contributions are threefold. First, we construct a novel longitudinal dataset of 121 cases of NSCLC patients that includes clinical encounters, diagnostic results, and medical histories, each expertly annotated with the corresponding NCCN guideline trajectories by board-certified oncologists. Second, we demonstrate that existing LLMs possess domain-specific knowledge that enables high-quality proxy benchmark generation for both model development and evaluation, achieving strong correlation (Spearman coefficient r=0.88, RMSE = 0.08) with expert-annotated benchmarks. Third, we develop a hybrid approach combining expensive human annotations with model consistency information to create both the agent framework that predicts the relevant guidelines for a patient, as well as a meta-classifier that verifies prediction accuracy with calibrated confidence scores for treatment recommendations (AUROC=0.800), a critical capability for communicating the accuracy of outputs, custom-tailoring tradeoffs in performance, and supporting regulatory compliance. This work establishes a framework for clinically viable LLM-based guideline adherence systems that balance accuracy, interpretability, and regulatory requirements while reducing annotation costs, providing a scalable pathway toward automated clinical decision support.